试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
960×540
pharmaphorum.com
Makary confirmed as Trump's FDA pick, with Weldon for CDC | pharmaphorum
960×540
pharmaphorum.com
AAD: J&J’s oral IL-23 drug shows durability in psoriasis | pharmaphorum
840×473
pharmaphorum.com
Sanofi's tolebrutinib cuts MS progression by 31% in trial | pharmaphorum
1200×675
pharmaphorum.com
Roche buys off-the-shelf CAR-T player Poseida for $1bn | pharmaphorum
960×540
pharmaphorum.com
Flagship closes $3.6bn biotech fund, with a focus on AI | pharmaphorum
1200×675
pharmaphorum.com
Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn | pharmaphorum
1200×675
pharmaphorum.com
MSD buys Modifi for $1.3bn to boost oncology pipeline | pharmaphorum
1200×675
pharmaphorum.com
CARsgen gets a win for CAR-T in solid tumours | pharmaphorum
900×600
pharmaphorum.com
Bayer bets on digital to deliver ‘precision’ consumer health | ph…
1200×675
pharmaphorum.com
Timeline: a history of medical imaging | pharmaphorum
1200×675
pharmaphorum.com
Sanofi in talks to sell stake in consumer health spinout | pharmaphorum
960×540
pharmaphorum.com
PBC drug choices rise in US with OK for Gilead's seladelpar | pharmaphorum
960×540
pharmaphorum.com
FDA approval gives BMS an edge in NSCLC treatment | pharmaphorum
1200×675
pharmaphorum.com
Lilly's Alzheimer's drug Kisunla is cleared in China | pharmaphorum
960×540
pharmaphorum.com
Novartis bid to block generic Entresto in US suffers setback | pharmaphorum
1200×675
pharmaphorum.com
Sanofi in talks to sell stake in consumer health spinout | pharmaphorum
960×540
pharmaphorum.com
Geron finally brings a drug to market as FDA clears Rytelo | pharmaphorum
960×540
pharmaphorum.com
AbbVie takes option on Gilgamesh CNS drugs in $2bn deal | pharmaphorum
1200×675
pharmaphorum.com
OrbiMed raises $4.3bn for latest biotech funds | pharmaphorum
960×540
pharmaphorum.com
AI firm Generate signs $1bn discovery deal with Novartis | pharmaphorum
1200×675
pharmaphorum.com
Sanofi takes SK Bio-partnered pneumococcal shot into phase 3 | pharmaphorum
1200×675
pharmaphorum.com
AbbVie gets continuous Parkinson's drug over the line in US | pharmaphorum
1600×900
pharmaphorum.com
Threats impacting the pharmaceutical industry in 2024 | pharmaphorum
900×500
pharmaphorum.com
Elon Musk’s Neuralink brain interface chip set for human trials | pharmaphorum
960×540
pharmaphorum.com
Pfizer’s new cancer unit sees eight new blockbusters by 2030 | pharmaphorum
1200×675
pharmaphorum.com
Chasing Novartis, Amgen ushers Lp(a) drug into phase 3 | pharmaphorum
2133×1600
deep-dive.pharmaphorum.com
Timeline: a history of medical imaging - pharmaphorum
960×540
pharmaphorum.com
FDA says yes to MSD’s 21-valent adult pneumococcal jab | pharmaphorum
960×540
pharmaphorum.com
In shock move, EU panel rejects Alzheimer's drug Leqembi | pharmaphor…
960×540
pharmaphorum.com
UCB bags FDA approval for second myasthenia gravis drug | pharmaphorum
960×540
pharmaphorum.com
Novartis cues up filings for remibrutinib in chronic hives | pharmaphorum
1200×675
pharmaphorum.com
Lundbeck planning for four novel drugs in phase 3 in 2026 | pharmaphorum
960×540
pharmaphorum.com
New VC Curie.bio makes its debut with $500m+ war chest | pharmaphorum
1200×675
pharmaphorum.com
FDA clears Neurocrine drug for rare adrenal disorder | pharmaphorum
960×540
pharmaphorum.com
Sanofi to invest €1bn in France to lift ‘health sovereignty’ | pharmaphorum
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈
反馈
